Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons

Neuroscience

Volumn 89, Issue 3, 1999, Pages 827-837

  Svenningsson, P ^a   Fourreau, L ^b   Bloch, B ^b   Fredholm, B B ^a   Gonon, F ^b   Le Moine, C ^b  

^a Sect Molec Neuropharmacology   (Sweden)

^b CNRS   (France)

Author keywords

Adenosine A(2A) receptors; c fos mRNA; Dopamine D2 receptors; Dopamine release; In situ hybridization; Striatum

Indexed keywords

ADENOSINE; DOPAMINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROCHEMICAL ANALYSIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DRUG DESIGN; GENE EXPRESSION REGULATION; GENES, FOS; GLOBUS PALLIDUS; IN SITU HYBRIDIZATION; MALE; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; PYRIMIDINES; QUINOLINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; TRIAZOLES; TYROSINE 3-MONOOXYGENASE;

EID: 0032913375     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00403-5     Document Type: Article

References (68)

1. Aprigliano O., Hermsmeyer K. In vitro denervation of the portal vein and caudal artery of the rat. J. Pharmac. exp. Ther. 198:1976;568-577.
2. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
3. Buda M., Gonon F., Cespuglio R., Jouvet M., Pujol J.F. In vivo electrochemical detection of catechols in several dopaminergic brain regions of anaesthetized rats. Eur. J. Pharmac. 73:1981;61-68.
4. Chen J.S., Kelz M.B., Hope B.T., Nakabeppu Y., Nestler E.J. Chronic fos-related antigens: stable variants of ΔFos B induced in brain by chronic treatments. J. Neurosci. 17:1997;4933-4941.
5. Chergui K., Svenningsson P., Nomikos G.G., Gonon F., Fredholm B.B., Svensson T. Increased expression of NGFI-A mRNA in rat striatum following burst stimulation of the medial forebrain bundle. Eur. J. Neurosci. 9:1997;2370-2382.
6. Cole D.G., DiFiglia M. Reserpine increases fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism. Neuroscience. 60:1994;115-123.
7. Cooper A.J., Moser B., Mitchell I.J. A subset of striatopallidal neurons are Fos-immunopositive following acute monoamine depletion in the rat. Neurosci. Lett. 187:1995;189-192.
8. Curran T., Gordon M.B., Rubino K.L., Sambucetti L.C. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-transcriptional modification in vitro. Oncogene. 2:1987;79-84.
9. Doucet J.P., Nakabeppu Y., Bedard P.J., Hope B.T., Nestler E.J., Jasmin B.J., Chen J.S., Iadarola M.J., St-Jean M., Wigle N., Blanchet P., Grondin R., Robertson G.S. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of ΔFos B-like protein(s) in both the rodent and primate striatum. Eur. J. Neurosci. 8:1996;365-381.
10. Dragunow M., Robertson G.S., Faull R.L. M., Robertson H.A., Jansen K. D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience. 37:1990;287-294.
11. Dugast C., Suaud-Chagny M.F., Gonon F. Continous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry. Neuroscience. 62:1994;647-654.
12. 2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmac. 321:1997;143-147.
13. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
14. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., Reppert S.M. Molecular cloning of the rat A2 adenosine receptor; selective co-expression with D2 dopamine receptors in rat striatum. Molec. Brain Res. 14:1992;186-195.
15. Fredholm B.B., Fuxe K., Agnati L. Effects of some phosphodiesterase inhibitors on central dopamine mechanisms. Eur. J. Pharmac. 38:1976;31-38.
16. Fredholm B.B., Herrera-Marschitz M., Jonzon B., Lindström K., Ungerstedt U. On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat. Pharmac. Biochem. Behav. 19:1983;535-541.
17. Fredholm B.B. Adenosine, adenosine receptors and the actions of caffeine. Pharmac. Toxicol. 75:1995;93-101.
18. Gerfen C.R., Young W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
19. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
20. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
21. Gerfen C. R. and Wilson C. J. (1996) The basal ganglia. In Handbook of Chemical Neuroanatomy, Integrated Systems of the CNS (eds Swanson L. W., Björklund A. and Hökfelt T.), Vol. 12, part III, pp. 371-468. Elsevier, Amsterdam.
22. Gonon F., Navarre F., Buda M. In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry. Analyt. Chem. 56:1984;573-575.
23. Gonon F. Nonlinear relationship between impulse flow and dopamine release by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
24. 1 receptors in the rat striatum in vivo. J. Neurosci. 17:1997;5972-5978.
25. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-253.
26. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix and limbic subdivisions of the striatum. Proc. natn. Acad. Sci. U.S.A. 87:1990;6912-6916.
27. Haeusler G. Early pre- and postjunctional effects of 6-hydroxydopamine. J. Pharmac. exp. Ther. 178:1971;49-62.
28. 2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15:1995;5222-5237.
29. 1 receptor with adenylate cyclase. J. Neurosci. 13:1993;2237-2248.
30. Jaber M., Robinson S.W., Missale C., Caron M.G. Dopamine receptors and brain function. Neuropharmacology. 35:1996;1503-1519.
31. Jackson D.M., Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioral aspects. Pharmac. Ther. 64:1994;291-369.
32. Jian M., Staines W.A., Iadarola M.J., Robertson G.S. Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatonigral neurons. Molec. Brain Res. 19:1993;156-160.
33. Jiang H., Jackson-Lewis V., Muthane U., Dollison A., Ferreira M., Espinosa A., Parsons B., Przedborski S. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behaviour in 6-hydroxydopamine-lesioned rats. Brain Res. 613:1993;347-351.
34. Keefe K.A., Zigmond M.J., Abercrombie E.D. In vivo regulation of extracellular dopamine in the neostriatum - influence of impulse activity and local excitatory amino acids. J. neural Transm. 91:1993;223-240.
35. Kostrzewa R.M., Jacobowitz D.M. Pharmacological actions of 6-hydroxydopamine. Pharmac. Rev. 26:1974;199-288.
36. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. natn. Acad. Sci. U.S.A. 87:1990;230-234.
37. Le Moine C., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. natn. Acad. Sci. U.S.A. 88:1991;4205-4209.
38. Le Moine C. and Bloch B. (1995) Anatomical and cellular analysis of dopamine receptor gene expression in striatal neurons. In Molecular Biology Series: Molecular and Cellular Mechanisms of Neostriatal Function (eds Ariano M. A. and Surmeier J. D.), pp. 45-57. R. G. Landes, Austin.
39. Le Moine C., Bernard V. and Bloch B. (1994) Quantitative in situ hybridization using radioactive probes: a protocol chapter to study gene expression in heterocellular systems. In Methods in Molecular Biology, In Situ Hybridization (ed. Choo K. H. A.), Vol. 33, pp. 301-311. Humana, Ottowa.
40. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. comp. Neurol. 355:1995;418-427.
41. 1 receptor-mediated effects on c-fos expression. J. Neurosci. 17:1997;8038-8048.
42. Mermet C., Gonon F. In vivo voltammetric monitoring of noradrenaline release and catecholamine metabolism in the hypothalamic paraventricular nucleus. Neuroscience. 19:1986;829-838.
43. Monsma F.J., McVittie L.D., Gerfen C.R., Mahan L.C., Sibley D.R. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature. 342:1989;926-929.
44. 1 dopamine receptor linked to adenylyl cyclase activation. Proc. natn. Acad. Sci. U.S.A. 87:1990;6723-6727.
45. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Pharmac. 251:1994;21-25.
46. 2A receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J. Neurosci. 16:1996;605-611.
47. Normand E., Popovici T., Onteniente B., Fellmann D., Piatier-Tonneau D., Auffray C., Bloch B. Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Brain Res. 439:1988;39-46.
48. 2A receptors. Trends pharmac. Sci. 17:1996;364-372.
49. 2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
50. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edn. Academic, North Ryde, Australia.
51. 1 agonists in dopamine-denervated rats. Eur. J. Neurosci. 8:1996;1176-1181.
52. 2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res. 759:1997;41-49.
53. 2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience. 68:1995;721-728.
54. 1 dopamine agonist on rotational behaviour and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats. Brain Res. 743:1996;124-130.
55. Raisman-Vozari R., Hirsch E., Javoy-Agid F., Vassort C., Savasta M., Feuerstein C., Thibault J., Agid Y. Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain. J. Neurochem. 57:1991;1212-1222.
56. Richardson P.J., Kase H., Jenner P. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends pharmac. Sci. 18:1997;338-344.
57. 1 dopamine receptor-activated c-fos. Brain Res. 523:1990;288-290.
58. 2 dopamine receptors differentially regulate c-fos expression in striato-nigral and striato-pallidal neurons. Neuroscience. 49:1992;285-296.
59. Schiffmann S.N., Vanderhaeghen J.J. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J. Neurosci. 13:1993;1080-1087.
60. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
61. Steiner H., Gerfen C.R. Cocaine-induced c-fos messenger mRNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
62. Svenningsson P., Nomikos G.G., Fredholm B.B. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J. Neurosci. 15:1995;7612-7624.
63. 2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expresssion of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience. 79:1997;753-764.
64. 2A receptor mRNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience. 80:1997;1171-1185.
65. 1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience. 72:1996;601-616.
66. 2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35:1994;85-91.
67. Young W.S., Bonner T.I., Brann M.R. Mesencephalic dopaminergic neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. natn. Acad. Sci. U.S.A. 83:1986;9827-9831.
68. Yung K.K. L., Smith A.D., Levey A.I., Bolam J.P. Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur. J. Neurosci. 8:1996;861-869.